New Key Statistics Module, Z-Score and F-Score
NAS:UTHR Key Ratios
| Market Cap $ M | 11,641.77 |
| Enterprise Value $ M | 9,343.64 |
| P/E(ttm) | 12.41 |
| PE Ratio without NRI | 12.41 |
| Forward PE Ratio | 11.19 |
| Price/Book | 2.17 |
| Price/Sales | 5.22 |
| Price/Free Cash Flow | 17.34 |
| Price/Owner Earnings | 15.89 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2,498.00 |
| EPS (TTM) $ | 21.15 |
| Beneish M-Score | -1.39 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 43.40 |
| EV-to-EBIT | 6.49 |
| EV-to-EBITDA | 6.25 |
| PEG | -- |
| Shares Outstanding M | 44.37 |
| Net Margin (%) | 42.05 |
| Operating Margin % | 50.31 |
| Pre-tax Margin (%) | 55.28 |
| Quick Ratio | 3.64 |
| Current Ratio | 3.77 |
| ROA % (ttm) | 15.58 |
| ROE % (ttm) | 19.05 |
| ROIC % (ttm) | 25.35 |
| Dividend Yield % | -- |
| Altman Z-Score | 8.86 |
UTHR Number of Guru Trades
UTHR Volume of Guru Trades
Gurus Latest Trades with NAS:UTHR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:UTHR is held by these investors
Total 6
United Therapeutics Corp Insider Transactions
No Available Data
News about NAS:UTHR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers